ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Rasilez 300 mg, Filmtabletten - 28 Tablette(n)
58050005 Future Health Pharma GmbH
Rasilez 300 mg, Filmtabletten29.06.2007
  29.06.2007
Aliskiren (C09XA02) 
WHO-DDD 
02.07.10.28 Tablette(n)
02.07.10. 
B  
Yes 
IPCI
25.73Yes
    
10 %46.00
7680580500058Synthetika
3581196 
Composition
aliskirenum 300 mg ut aliskireni hemifumaras, cellulosum microcristallinum, crospovidonum, povidonum K 30, silica colloidalis anhydrica, magnesii stearas, Überzug: macrogolum 4000, talcum, hypromellosum, E 171, E 172 (rubrum), E 172 (nigrum), pro compresso obducto.
Packungsbestandteile
Coated tablets 
 
Active AgentDose
Aliskirenum300 mg
BAG: Active AgentDose
Aliskirenum300 mg
 
Inactive agentsDoseadditional_information
(Nigrum)  
(Rubrum)  
Cellulosum Microcristallinum  
Crospovidonum  
E 171 color.
E 172 color.
Hypromellosum  
Macrogol4000 Überzug
Magnesii Stearas  
Povidonum K30  
Pro Compresso Obducto  
Silica Colloidalis Anhydrica  
Talcum  
 
Source
Data was imported : 07.02.2023 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :
 
2024 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home